NEW YORK (GenomeWeb News) –Molecular Devices will distribute De Novo Software's FCS Express 4 software under a licensing agreement announced today.
Under the terms of the deal, Molecular Devices will distribute the software to customers in the research and pharmaceutical markets worldwide. Further terms of the deal were not disclosed.
In FCS Express 4, analytical tools for flow and image cytometry and high-content screening are combined in one environment with report generation and online collaboration tools, the companies said. The software, which was launched by De Novo in January, adds the ability to access and interactively perform population-based analysis, while linking back to the individual images underlying the data.
"This enables highlighting of individual cells in an image from selected populations or display of single cells of interest in separate cell galleries," Molecular Devices and De Novo said in a joint statement. The tools improve assay development and workflow and enable rapid report generation, they added.